Literature DB >> 26022518

Intrahepatic and hilar mass-forming cholangiocarcinoma: Qualitative and quantitative evaluation with diffusion-weighted MR imaging.

Hassan El Fattach1, Anthony Dohan2, Youcef Guerrache3, Raphael Dautry4, Mourad Boudiaf5, Christine Hoeffel6, Philippe Soyer7.   

Abstract

OBJECTIVE: To qualitatively and quantitatively analyze the presentation of intrahepatic and hilar mass-forming cholangiocarcinoma with diffusion-weighted magnetic resonance imaging (DW-MRI).
MATERIALS AND METHODS: Twenty-eight patients with histopathologically proven mass-forming cholangiocarcinoma (hilar, n=17; intrahepatic, n=11) underwent hepatic DW-MRI at 1.5-T using free-breathing acquisition and three b-values (0,400,800s/mm(2)). Cholangiocarcinomas were evaluated qualitatively using visual analysis of DW-MR images and quantitatively with conventional ADC and normalized ADC measurements using liver and spleen as reference organs.
RESULTS: All cholangiocarcinomas (28/28; 100%) were visible on DW-MR images. DW-MRI yielded best conspicuity of cholangiocarcinomas than the other MRI sequences (P<0.001). Seven cholangiocarcinomas (7/11; 64%) showed hypointense central area on DW-MR images. Conventional ADC value of cholangiocarcinomas (1.042×10(-3)mm(2)/s±0.221×10(-3)mm(2)/s; range: 0.616×10(-3)mm(2)/s to 2.050×10(-3)mm(2)/s) was significantly lower than that of apparently normal hepatic parenchyma (1.362×10(-3)mm(2)/s±0.187×10(-3)mm(2)/s) (P<0.0001), although substantial overlap was found. No significant differences in ADC and normalized ADC values were found between intrahepatic and hilar cholangiocarcinomas. The use of normalized ADC using the liver as reference organ resulted in the most restricted distribution of ADC values of cholangiocarcinomas (variation coefficient=16.6%).
CONCLUSION: There is a trend towards a common appearance of intrahepatic and hilar mass-forming cholangiocarcinomas on DW-MRI but variations may be observed. Familiarity with these variations may improve the diagnosis of mass-forming cholangiocarcinoma.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Diffusion-weighted magnetic resonance imaging; Hilar cholangiocarcinoma; Intrahepatic cholangiocarcinoma; MR Imaging; Malignant hepatic tumor; Normalized ADC

Mesh:

Year:  2015        PMID: 26022518     DOI: 10.1016/j.ejrad.2015.05.003

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  8 in total

1.  Mass-forming intrahepatic cholangiocarcinoma: Enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings.

Authors:  Nobuhiro Fujita; Yoshiki Asayama; Akihiro Nishie; Kousei Ishigami; Yasuhiro Ushijima; Yukihisa Takayama; Daisuke Okamoto; Koichiro Moirta; Ken Shirabe; Shinichi Aishima; Huanlin Wang; Yoshinao Oda; Hiroshi Honda
Journal:  Eur Radiol       Date:  2016-05-10       Impact factor: 5.315

Review 2.  Multimodality imaging of intrahepatic cholangiocarcinoma.

Authors:  Kelly Fábrega-Foster; Mounes Aliyari Ghasabeh; Timothy M Pawlik; Ihab R Kamel
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

3.  Prediction of the histopathologic findings of intrahepatic cholangiocarcinoma: qualitative and quantitative assessment of diffusion-weighted imaging.

Authors:  Sara Lewis; Cecilia Besa; Mathilde Wagner; Kartik Jhaveri; Shingo Kihira; Hongfa Zhu; Nima Sadoughi; Sandra Fischer; Amogh Srivastava; Eric Yee; Koenraad Mortele; James Babb; Swan Thung; Bachir Taouli
Journal:  Eur Radiol       Date:  2017-12-12       Impact factor: 5.315

4.  The Evaluation of Zoomed Echo-Planar Diffusion-Weighted Magnetic Resonance Imaging With Two-dimensional Spatial-Selective Radiofrequency Excitation Pulses in Patients With Hilar Cholangiocarcinoma.

Authors:  Jingjing Liu; Mengyue Huang; Yanan Ren; Man Xu; Yinhua Li; Jingliang Cheng; Jinxia Zhu
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

5.  Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.

Authors:  Vincenza Granata; Roberta Fusco; Orlando Catalano; Antonio Avallone; Raffaele Palaia; Gerardo Botti; Fabiana Tatangelo; Francesco Granata; Marco Cascella; Francesco Izzo; Antonella Petrillo
Journal:  PLoS One       Date:  2017-06-20       Impact factor: 3.240

6.  Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features.

Authors:  Michael J King; Stefanie Hectors; Karen M Lee; Olamide Omidele; James S Babb; Myron Schwartz; Parissa Tabrizian; Bachir Taouli; Sara Lewis
Journal:  Cancer Imaging       Date:  2020-07-03       Impact factor: 3.909

7.  The Application Value of MRI T2WI Radiomics Nomogram in Discriminating Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma.

Authors:  Feng Huang; Xiaoyun Liu; Peng Liu; Dan Xu; Zeda Li; Huashan Lin; An Xie
Journal:  Comput Math Methods Med       Date:  2022-09-27       Impact factor: 2.809

8.  Intrahepatic cholangiocarcinoma in the setting of HBV-related cirrhosis: Differentiation with hepatocellular carcinoma by using Intravoxel incoherent motion diffusion-weighted MR imaging.

Authors:  Yi Wei; Feifei Gao; Dandan Zheng; Zixing Huang; Min Wang; Fubi Hu; Chenyang Chen; Ting Duan; Jie Chen; Likun Cao; Bin Song
Journal:  Oncotarget       Date:  2017-12-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.